跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要研究合成控制的处理效应估计,并以供体面板的时间谱分解构造匹配。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Mojtaba Eslami

合成控制中的谱截断

研究问题
将合成控制的处理前轨迹匹配改为主要时间奇异向量上的匹配,何时有益,何时会因截断与预处理方式产生更大误差?
方法与思路
作者研究谱合成控制及可调保留、舍弃方向权重的混合估计量,推导平衡与偏差关系,并用供体安慰剂验证选择调参。
材料陈述的贡献
摘要称,原始输入下截断方法在全部模拟情形中误差更高;去除个体与时间固定效应后差距接近消失,混合方法多选择原轨迹。
阅读关注点
应核对权重约束下仿射解集的含义、偏差分解条件、供体安慰剂调参流程,以及预处理如何改变谱基底和比较结果。
阅读边界
这是 arXiv 预印本,同行评审与接收未经核实;模拟比较仅覆盖所设情形,摘要将结果定位为诊断,未主张谱方法普遍替代传统方法。

原文摘要

Synthetic control (SC) matches a treated unit's pre-treatment trajectory to a weighted combination of donor units. We study Spectral SC, which instead matches the treated unit in coordinates defined by the leading temporal singular vectors of the donor panel, and a hybrid estimator that places separately tunable weight on retained and discarded directions, nesting raw-path SC and truncated Spectral SC as endpoints. We prove that the family reduces exactly to raw-path SC at full rank, that exact balance on $K$ retained dimensions with $N_0$ donors is underdetermined whenever $N_0>K+1$, with an affine solution set of dimension $N_0-K-1$, and that spectral imbalance maps to treatment-effect bias through a finite-sample best-linear-predictor decomposition. We evaluate the estimators across eleven data-generating regimes, using $400$ replications per regime and donor-only placebo validation to select regularization and the mixing weight. Truncated Spectral SC has significantly higher RMSE than tuned raw-path SC in every regime, with paired differences equal to $4$ to $11$ Monte Carlo standard errors. The hybrid estimator selects raw-path matching in most replications and is statistically indistinguishable from tuned SC in most regimes. The result is highly sensitive to preprocessing. With raw inputs, the performance gap is large; after removing unit and time fixed effects before spectral decomposition, as suggested by the assumptions behind our bound, the gap nearly disappears and placebo validation begins to favor truncation. We interpret these findings diagnostically rather than as evidence that Spectral SC should replace raw-path SC. Basis-estimation noise, balancing underdetermination, and fixed-effects contamination determine when spectral matching can help.

笔记与分组